_2020091018165303jzv.jpg "Decoding The World Of ETF")
- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Sep 21, 16:00Prev. Close
258.45
Open Price
262.90
Bid Price (Qty.)
248.10 (100)
Offer Price (Qty.)
251.40 (1)
NSE Live
Sep 21, 15:58Prev. Close
258.90
Open Price
260.10
Bid Price (Qty.)
250.85 (20)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of Unichem Laboratories (in Rs. Cr.) | Jun '20 | Mar '20 | Dec '19 | Sep '19 | Jun '19 | |
| Net Sales/Income from operations | 240.77 | 216.07 | 231.20 | 225.10 | 232.52 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 240.77 | 216.07 | 231.20 | 225.10 | 232.52 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 107.87 | 86.31 | 110.92 | 102.18 | 100.79 | |
| Purchase of Traded Goods | 0.05 | 0.38 | 0.09 | 0.21 | 0.36 | |
| Increase/Decrease in Stocks | 1.12 | -6.65 | -14.75 | 4.19 | -1.29 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 59.56 | 53.35 | 50.82 | 52.12 | 48.86 | |
| depreciat | 18.31 | 19.11 | 17.26 | 17.86 | 16.86 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 79.97 | 93.65 | 109.82 | 102.21 | 101.91 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -26.12 | -30.09 | -42.96 | -53.68 | -34.97 | |
| Other Income | 18.73 | 19.13 | 23.01 | 29.05 | 27.98 | |
| P/L Before Int., Excpt. Items & Tax | -7.39 | -10.96 | -19.95 | -24.63 | -6.99 | |
| Interest | 0.16 | 0.59 | 0.42 | 0.23 | 0.05 | |
| P/L Before Exceptional Items & Tax | -7.55 | -11.54 | -20.37 | -24.86 | -7.03 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | -7.55 | -11.54 | -20.37 | -24.86 | -7.03 | |
| Tax | -- | 0.00 | -- | -- | -7.50 | |
| P/L After Tax from Ordinary Activities | -7.55 | -11.55 | -20.37 | -24.86 | 0.46 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | -7.55 | -11.55 | -20.37 | -24.86 | 0.46 | |
| Equity Share Capital | 14.08 | 14.08 | 14.08 | 14.08 | 14.08 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | -1.07 | -1.65 | -2.89 | -3.53 | 0.07 | |
| Diluted EPS | -1.07 | -1.65 | -2.89 | -3.53 | 0.07 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | -1.07 | -1.65 | -2.89 | -3.53 | 0.07 | |
| Diluted EPS. | -1.07 | -1.65 | -2.89 | -3.53 | 0.07 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
05.08.2020
Unichem Labs Consolidated June 2020 Net Sales at Rs 317.27 crore, up 6.56% Y-o-Y
05.08.2020
Unichem Labs Standalone June 2020 Net Sales at Rs 240.77 crore, up 3.55% Y-o-Y
22.06.2020
Unichem Labs Standalone March 2020 Net Sales at Rs 216.07 crore, down 22.02% Y-o-Y
22.06.2020
Unichem Labs Consolidated March 2020 Net Sales at Rs 320.23 crore, down 14.43% Y-o-Y
